Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J. Nastoupil, Frederick L. Locke, André Goy et al.|Journal of Clinical Oncology|2020Cited by 782
<i>DNMT3A</i> Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous LeukemiaAlison R. Sehgal, Martin Carroll, Phyllis A. Gimotty et al.|Clinical Cancer Research|2015Cited by 55
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid LeukemiaCaroline E. Sloan, Martin Carroll, Marlise R. Luskin et al.|PLoS ONE|2016Cited by 10
Acute Cholecystitis Is a Common Complication after Allogeneic Stem Cell Transplantation and Is Associated with the Use of Total Parenteral NutritionStephen Bagley, Selina M. Luger, Alison R. Sehgal et al.|Transplantation and Cellular Therapy|2014Cited by 9
Predicting prognosis in patients with acute myeloid leukemia: The role of next-generation sequencing and mutational profiling.Caroline E. Sloan, Martin Carroll, Phyllis A. Gimotty et al.|Journal of Clinical Oncology|2014Cited by 1